{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:04:32Z","timestamp":1789045472596,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hebei Provincial Key R&D Program Project","award":["no.22377745D"],"award-info":[{"award-number":["no.22377745D"]}]},{"name":"Hebei Natural Science Foundation Project","award":["no.H2022108003"],"award-info":[{"award-number":["no.H2022108003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03427-0","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T07:03:00Z","timestamp":1727679780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of skeletal muscle index on post-embolization syndrome of hepatocellular carcinoma after transarterial chemoembolization"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaojuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuopeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoufang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruikun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linglei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"issue":"3","key":"3427_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3427_CR2","doi-asserted-by":"crossref","unstructured":"Jiang D, Zhang L, Liu W et al. Trends in cancer mortality in China from 2004 to 2018: a nationwide longitudinal study. Cancer Commun (Lond). 2021;41(10):1024\u201336.","DOI":"10.1002\/cac2.12195"},{"issue":"02","key":"3427_CR3","first-page":"16","volume":"8","author":"NATIONAL HEALTH COMMISSION OF THE","year":"2022","unstructured":"NATIONAL HEALTH COMMISSION OF THE, S REPUBLIC OF CHINA. Primary Liver Cancer diagnosis and treatment guidelines (2022 edition). Electron J Integr Cancer Therapy. 2022;8(02):16\u201353.","journal-title":"Electron J Integr Cancer Therapy"},{"issue":"10","key":"3427_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jvir.2012.07.003","volume":"23","author":"HJ Prajapati","year":"2012","unstructured":"Prajapati HJ, Rafi S, El-Rayes BF, Kauh JS, Kooby DA, Kim HS. Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transarterial chemoembolization. J VASC INTERV RADIOL. 2012;23(10):1286\u201393.","journal-title":"J VASC INTERV RADIOL"},{"issue":"2","key":"3427_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jvir.2008.10.021","volume":"20","author":"JH Shim","year":"2009","unstructured":"Shim JH, Park JW, Choi JI, Kim HB, Lee WJ, Kim CM. Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma? J VASC INTERV RADIOL. 2009;20(2):209\u201316.","journal-title":"J VASC INTERV RADIOL"},{"issue":"3","key":"3427_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1051-0443(07)61911-3","volume":"12","author":"DA Leung","year":"2001","unstructured":"Leung DA, Goin JE, Sickles C, Raskay BJ, Soulen MC. Determinants of postembolization syndrome after hepatic chemoembolization. J VASC INTERV RADIOL. 2001;12(3):321\u20136.","journal-title":"J VASC INTERV RADIOL"},{"issue":"6","key":"3427_CR7","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2214\/AJR.21.26806","volume":"218","author":"AA Rmilah","year":"2022","unstructured":"Rmilah AA, Qrareya MN, Fleming C, Alkurashi AK, Nyberg S, Leise M, Andrews JC. Association of Cirrhosis and other patient and procedural characteristics with postembolization syndrome after bland hepatic artery embolization for hepatic malignancy. AM J ROENTGENOL. 2022;218(6):1030\u20139.","journal-title":"AM J ROENTGENOL"},{"key":"3427_CR8","doi-asserted-by":"crossref","unstructured":"Roehlen N, Stoehr F, M\u00fcller L, Luxenburger H, Gairing SJ, Reincke M, Schultheiss M, Berisha F, Weinmann A, Foerster F et al. Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis. Hepatol Commun 2023, 7(10).","DOI":"10.1097\/HC9.0000000000000252"},{"key":"3427_CR9","doi-asserted-by":"publisher","unstructured":"D\u2019Arcangelo F, Zanetto A, Ferrarese A, Gambato M, Lanari J, Piano S, Germani G, Senzolo M, Russo FP, Angeli P et al. Frailty and Sarcopenia in patients with cirrhosis awaiting liver transplantation: evidence from a single-centre, prospective cohort study. Updates Surg 2024. https:\/\/doi.org\/10.1007\/s13304-024-01962-9n","DOI":"10.1007\/s13304-024-01962-9n"},{"issue":"6","key":"3427_CR10","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1177\/00031348241241713","volume":"90","author":"T Polvieng","year":"2024","unstructured":"Polvieng T, Hongjinda S, Thienhiran A, Burasakarn P, Fuengfoo P. Effect of Sarcopenia on the prognosis of clinical outcomes in patients with Hepatocellular Carcinoma after hepatic resection. Am Surg. 2024;90(6):1447\u201355.","journal-title":"Am Surg"},{"key":"3427_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/JHC.S444530","volume":"11","author":"H Yang","year":"2024","unstructured":"Yang H, Cong T, Luo Y, Yang C, Ren J, Li X. Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma patients targeted with interventional therapy combined with immunotherapy and targeted therapy. J Hepatocell Carcinoma. 2024;11:175\u201389.","journal-title":"J Hepatocell Carcinoma"},{"key":"3427_CR12","doi-asserted-by":"publisher","first-page":"1342100","DOI":"10.3389\/fnut.2023.1342100","volume":"10","author":"Y Cui","year":"2023","unstructured":"Cui Y, Zhang M, Guo J, Jin J, Wang H, Wang X. Correlation between Sarcopenia and cirrhosis: a meta-analysis. Front Nutr. 2023;10:1342100.","journal-title":"Front Nutr"},{"issue":"1","key":"3427_CR13","first-page":"389","volume":"16","author":"J Long","year":"2024","unstructured":"Long J, Zhang X, Mi W, Shi J, Ren H, Wang Q. The predictive value of Sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients. Aging. 2024;16(1):389\u2013401.","journal-title":"Aging"},{"issue":"05","key":"3427_CR14","first-page":"321","volume":"12","author":"B Yang","year":"2009","unstructured":"Yang B, Cong W, Zhou X, et al. Expert consensus on standardized diagnosis and treatment of primary liver cancer. J Practical Liver Dis. 2009;12(05):321\u20138.","journal-title":"J Practical Liver Dis"},{"issue":"3","key":"3427_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/0148607115604149","volume":"40","author":"SL Gomez-Perez","year":"2016","unstructured":"Gomez-Perez SL, Haus JM, Sheean P, Patel B, Mar W, Chaudhry V, McKeever L, Braunschweig C. Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: a step-by-step guide for Clinicians Using National Institutes of Health ImageJ. JPEN J Parenter Enter Nutr. 2016;40(3):308\u201318.","journal-title":"JPEN J Parenter Enter Nutr"},{"issue":"6","key":"3427_CR16","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/jcsm.12797","volume":"12","author":"X Zeng","year":"2021","unstructured":"Zeng X, Shi ZW, Yu JJ, Wang LF, Luo YY, Jin SM, Zhang LY, Tan W, Shi PM, Yu H, et al. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle. 2021;12(6):1948\u201358.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"3427_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12885-021-08253-1","volume":"21","author":"H Lu","year":"2021","unstructured":"Lu H, Zheng C, Liang B, Xiong B. Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis. BMC Cancer. 2021;21(1):513.","journal-title":"BMC Cancer"},{"key":"3427_CR18","doi-asserted-by":"crossref","unstructured":"Roehlen N, Stoehr F, Muller L, Luxenburger H, Gairing SJ, Reincke M, Schultheiss M, Berisha F, Weinmann A, Foerster F et al. Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis. Hepatol Commun 2023, 7(10).","DOI":"10.1097\/HC9.0000000000000252"},{"issue":"6","key":"3427_CR19","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.clinre.2024.102344","volume":"48","author":"X Pan","year":"2024","unstructured":"Pan X, Hu E, Zhou Y, Li L, Huang X, Cai Z. The prognostic nutritional index as a predictor of efficacy and early recurrence for adjuvant transarterial chemoembolization in hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2024;48(6):102344.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"6","key":"3427_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/02841851241229185","volume":"65","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liu Z, Li X, Zhou W, Lin L, Chen X. Non-invasive assessment of response to transarterial arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics nomogram. ACTA RADIOL. 2024;65(6):535\u201345.","journal-title":"ACTA RADIOL"},{"issue":"8","key":"3427_CR21","doi-asserted-by":"publisher","first-page":"e18494","DOI":"10.1016\/j.heliyon.2023.e18494","volume":"9","author":"K Lei","year":"2023","unstructured":"Lei K, Wang JG, Li Y, Wang HX, Xu J, You K, Liu ZJ. Prognostic value of preoperative prealbumin levels in patients with unresectable hepatocellular carcinoma undergoing transarterial arterial chemoembolisation. Heliyon. 2023;9(8):e18494.","journal-title":"Heliyon"},{"issue":"5","key":"3427_CR22","doi-asserted-by":"publisher","first-page":"e95485","DOI":"10.1371\/journal.pone.0095485","volume":"9","author":"YG Wang","year":"2014","unstructured":"Wang YG, Wang P, Wang B, Fu ZJ, Zhao WJ, Yan SL. Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis. PLoS ONE. 2014;9(5):e95485.","journal-title":"PLoS ONE"},{"issue":"1","key":"3427_CR23","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/s41598-024-53711-y","volume":"14","author":"J Bai","year":"2024","unstructured":"Bai J, Huang M, Zhou J, Song B, Hua J, Ding R. Development of a predictive nomogram for postembolization syndrome after transarterial arterial chemoembolization of hepatocellular carcinoma. Sci Rep. 2024;14(1):3303.","journal-title":"Sci Rep"},{"issue":"1","key":"3427_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1148\/radiol.2018180257","volume":"290","author":"MH Khalaf","year":"2019","unstructured":"Khalaf MH, Sundaram V, AbdelRazek MM, Shah R, Khosla A, Jackson K, Desai M, Kothary N. A predictive model for postembolization syndrome after transarterial hepatic chemoembolization of Hepatocellular Carcinoma. Radiology. 2019;290(1):254\u201361.","journal-title":"Radiology"},{"issue":"3","key":"3427_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"L Chen","year":"2020","unstructured":"Chen L, Woo J, Assantachai P, Auyeung T, Chou M, Iijima K, Jang HC, Kang L, Kim M, Kim S, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia diagnosis and treatment. J AM MED DIR ASSOC. 2020;21(3):300\u20137.","journal-title":"J AM MED DIR ASSOC"},{"issue":"1","key":"3427_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, et al. Sarcopenia: revised European consensus on definition and diagnosis. AGE AGEING. 2019;48(1):16\u201331.","journal-title":"AGE AGEING"},{"issue":"1","key":"3427_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","volume":"38","author":"T Cederholm","year":"2019","unstructured":"Cederholm T, Jensen GL, Correia M, Gonzalez MC, Fukushima R, Higashiguchi T, Baptista G, Barazzoni R, Blaauw R, Coats A, et al. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. CLIN NUTR. 2019;38(1):1\u20139.","journal-title":"CLIN NUTR"},{"key":"3427_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/hepr.12537","volume":"46","author":"S Itoh","year":"2016","unstructured":"Itoh S, Shirabe K, Yoshizumi T, et al. Skeletal muscle mass assessed by computed tomography correlates to muscle strength and physical performance at a liver-related hospital experience. Hepatol Res. 2016;46:292\u20137.","journal-title":"Hepatol Res"},{"issue":"4","key":"3427_CR29","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.31557\/APJCP.2023.24.4.1143","volume":"24","author":"V Jaruvongvanich","year":"2023","unstructured":"Jaruvongvanich V, Thamtorawat S, Saiviroonporn P, Pisanuwongse A, Siriwanarangsun P. Sarcopenia as a Predictive Factor for Recurrence of Hepatocellular Carcinoma Following Radiofrequency Ablation. Asian Pac J Cancer Prev. 2023;24(4):1143\u201350.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3427_CR30","doi-asserted-by":"crossref","unstructured":"Marasco G, Dajti E, Serenari M, Alemanni LV, Ravaioli F, Ravaioli M, Vestito A, Vara G, Festi D, Golfieri R et al. Sarcopenia predicts major complications after resection for primary Hepatocellular Carcinoma in compensated cirrhosis. Cancers (Basel) 2022, 14(8).","DOI":"10.3390\/cancers14081935"},{"issue":"2","key":"3427_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000504604","volume":"9","author":"H Uojima","year":"2020","unstructured":"Uojima H, Chuma M, Tanaka Y, Hidaka H, Nakazawa T, Iwabuchi S, Kobayashi S, Hattori N, Ogushi K, Morimoto M, et al. Skeletal muscle Mass influences Tolerability and Prognosis in Hepatocellular Carcinoma patients treated with Lenvatinib. Liver Cancer. 2020;9(2):193\u2013206.","journal-title":"Liver Cancer"},{"issue":"2","key":"3427_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000488779","volume":"8","author":"Y Hamaguchi","year":"2019","unstructured":"Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, et al. Preoperative Visceral Adiposity and Muscularity Predict Poor outcomes after Hepatectomy for Hepatocellular Carcinoma. Liver Cancer. 2019;8(2):92\u2013109.","journal-title":"Liver Cancer"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03427-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03427-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03427-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T19:05:33Z","timestamp":1727723133000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03427-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3427"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03427-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Human Ethics Committee of Xingtai People\u2019s Hospital(Approval Letter NO.(2023 [104])). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"333"}}